Home › Funds › Venrock Adviser, LLC › ERAS

Venrock Adviser, LLC position in ERAS

ERASCA INC · Health Care

Venrock Adviser, LLC reported holding 17,891,812 shares of ERAS (ERASCA INC) in its Q2 2026 13F filing — a position valued at US$327.8M, representing 9.94% of its reported portfolio and ranking #3 among its reported holdings. Venrock Adviser, LLC has disclosed ERAS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)17.89M sh
Reported value held$327.78M
Portfolio Weight9.94%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's ERAS position evolved

Venrock Adviser, LLC first disclosed a stake in ERAS in Q2 2024 at 16,216,216 shares (US$38.3M). The position peaked in Q2 2026 at 17,891,812 shares, worth US$327.8M. Across 9 filings, Venrock Adviser, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 17,891,812 shares valued at US$327.8M — an increase of 1,509,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2024 16.22M $38.27M New
Q3 2024 16.22M $44.27M Hold
Q4 2024 16.22M $40.70M Hold
Q1 2025 16.22M $22.22M Hold
Q2 2025 17.86M $22.68M Add
Q3 2025 17.86M $38.93M Hold
Q4 2025 17.86M $66.43M Hold
Q1 2026 16.38M $265.07M Reduce
Q2 2026 17.89M $327.78M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ERAS and 13F data

ERAS (ERASCA INC) is a Health Care company. 78 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$328.8M), Logos Global Management LP (US$222.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ERAS

All ERAS fund holders →

FAQ

How long has Venrock Adviser, LLC held ERAS?

Venrock Adviser, LLC has disclosed ERAS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is Venrock Adviser, LLC's current position in ERAS?

As of Q2 2026, Venrock Adviser, LLC holds 17.89M shares of ERAS (ERASCA INC), valued at $327.78M, representing 9.94% of its reported portfolio and ranking #3.

Has Venrock Adviser, LLC been buying or selling ERAS?

In the latest 13F filing (Q2 2026), Venrock Adviser, LLC increased its position in ERAS. The position peaked in Q2 2026 at 17.89M shares.

Which other funds hold ERAS?

Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Logos Global Management LP, among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.